Denmark IV Equipment Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Denmark IV Equipment Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Denmark IV Equipment Market analysis

Part of: IV Equipment Market (Global)

The Denmark IV Equipment Market was valued at $54.8 Million in 2026 and projected to reach to $73.73 Million by 2031, representing a compound annual growth rate of 6.1%. Denmark's IV Equipment Market demonstrates stable growth driven by an aging population requiring enhanced intravenous therapies and Denmark's commitment to healthcare modernization.

Denmark IV Equipment Market (2026-2031) : Size and Share

CAGR of

USD Million

Denmark IV Equipment Market Trends and Insights

Denmark's healthcare infrastructure and aging population are driving demand for advanced intravenous delivery systems and infusion technologies.
The market in Denmark reflects strong adoption of modern medical devices within the country's well-developed healthcare system. Growth in Denmark's IV Equipment Market is supported by increasing prevalence of chronic diseases, rising hospital admissions, and Denmark's commitment to healthcare modernization.
Between 2026 and 2031, Denmark is expected to see steady expansion driven by technological innovations in infusion pumps, catheters, and related accessories.
Denmark's regulatory environment and emphasis on patient safety continue to shape product development and market entry strategies for IV equipment manufacturers..

Key Market Statistics

CAGR (2026-2031) 6.1% CAGR
Market Size, 2026 ~USD 54.8 Million
Forecast, 2031 ~USD 73.73 Million
Country Denmark

Denmark IV Equipment Market Overview

Market Size & Growth :

Denmark's IV Equipment Market is valued at USD 54.8 million in 2026, expanding to USD 73.73 million by 2031 at a steady 6.1% CAGR, reflecting consistent healthcare investment and modernization.

Aging Population Driver :

Denmark's demographic shift toward an older population increases chronic disease prevalence and hospitalization rates, directly boosting demand for advanced intravenous delivery systems and infusion technologies.

Healthcare Infrastructure Excellence :

Denmark's robust healthcare system and high medical device adoption rates create a favorable environment for premium IV equipment solutions and innovative infusion technologies.

Regulatory & Quality Standards :

Stringent Danish and EU regulatory frameworks ensure high-quality IV equipment standards, supporting market growth through increased adoption of certified advanced medical devices.

Denmark IV Equipment Market Dynamics

The country's advanced healthcare infrastructure and high per-capita healthcare spending support adoption of sophisticated infusion technologies and delivery systems.
Over the 2026-2031 forecast period, the market will benefit from increasing prevalence of chronic conditions, expanded hospital capacity, and integration of digital health solutions in IV administration.
Denmark's alignment with EU medical device regulations ensures continuous innovation and market expansion, positioning it as a mature, quality-focused market with sustained demand for premium IV equipment solutions..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
CONMED Corporation

Key Takeaways

Denmark's IV Equipment Market is valued at USD 54.8 million in 2026 and will reach USD 73.73 million by 2031.
Denmark maintains a 6.1% CAGR throughout the forecast period, reflecting consistent healthcare investment and modernization.
Denmark's aging demographic and chronic disease burden are primary drivers of IV equipment demand.
Denmark's stringent regulatory standards and advanced healthcare infrastructure support premium product adoption and innovation.

IV Equipment Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	NEEDLE-FREE CONNECTORS & EXTENSION SETS (Type)
Forecast Period	2026�2031
Growth Rate	CAGR of 6.1% from 2026 to 2031
Largest Segment	HOSPITALS (End User)
Market Size Base Year (Billions)	~USD 17.79 (2026)
Revenue Forecast (Billions)	~USD 23.92 (2031)
Segments Covered	Type, Application, End User

Denmark IV Equipment Market Report Segmentation

3 segment dimensions are covered across the global market.

By Type

Analgesia/Pain Management
Antibiotic/Antimicrobial Iv Therapy
Critical Care & Vasoactive Drug Infusion
Critical Care Nutrition
Gastrointestinal Disorders
Immunotherapy
Infusion Pumps
Iv Administration Sets & Tubing
Iv Catheters
Iv Drip Chambers
Needle-Free Connectors & Extension Sets
Neonatal & Pediatric Parenteral Nutrition
Oncology (Iv Chemotherapy)
Other Blood & Blood Products Transfusion Applications
Other Iv Equipment
Other Parenteral Nutrition Applications
Plasma Transfusion
Platelet Transfusion
Red Blood Cell Transfusion
Securement & Stabilization Devices
Sedation & Anesthesia Infusion

By Application

Blood & Blood Products Transfusion
Diagnostic Testing
Fluid & Electrolyte Replacement
Medication Administration
Other Applications
Parenteral Nutrition (Pn)

By End User

Ambulatory Surgical Centers
Ambulatory Surgical Centers (Ascs)
Home Care Settings
Hospitals
Other End Users
Outpatient Infusion & Specialty Clinics

Target Audience

Medical Device Manufacturers : IV equipment and infusion technology producers need Denmark-specific market data to assess market entry viability, competitive landscape, and growth opportunities in this mature Nordic healthcare market.
Healthcare Facility Operators : Danish hospitals, clinics, and care centers require market insights to optimize IV equipment procurement strategies, evaluate supplier options, and align purchasing with market trends and innovations.
Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in Denmark need precise market sizing, growth forecasts, and demographic drivers to assess portfolio companies and acquisition targets in IV equipment.
Healthcare Consultants & Advisors : Strategy consultants supporting Danish healthcare organizations require detailed market analysis to develop business plans, competitive strategies, and technology adoption roadmaps for IV equipment solutions.
Regulatory & Compliance Officers : Healthcare compliance professionals need Denmark-specific regulatory context and market standards to ensure IV equipment procurement meets local requirements and EU directives.

Key Companies in the Denmark IV Equipment Market

Company	HQ	Ownership	Strongest segments
KINDRED HEALTHCARE INC.	United States	Private Company	Long-term acute care hospital drug utilization,Inpatient rehabilitation facility drug utilization,Contract rehabilitation and ancillary services,
ATS AUTOMATION TOOLING SYSTEMS INC	Canada	Public Company	Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Contract manufacturing and value engineering,
CONVATEC	United Kingdom	Public Company	Advanced wound care,Ostomy care,Continence and critical care,
IRADIMED CORPORATION	United States	Public Company	MRidium 3870/3860+ MRI-compatible infusion pump systems and disposables,3880 MRI-compatible patient vital signs monitoring system and accessories,3600 FMD1 ferromagnetic detection devices and remote alarm units,
POLY MEDICURE LTD.	India	Public Company	Infusion & Transfusion Therapy,Critical Care & Anesthesia/Respiratory,Dialysis & Renal Care,
CONMED CORPORATION	United States	Public Company	Sports medicine & soft tissue fixation (BioBrace, Y-Knot, TruShot, Agro Knotless),Powered large & small bone systems (Hall brand),General surgery � insufflation & smoke management (AirSeal, Buffalo Filter),
MALLINCKRODT PLC	Ireland	Private Company	Autoimmune and rare disease therapies,Neurology and rheumatology specialty products,Neonatal respiratory and critical care therapies,
BECTON, DICKINSON AND COMPANY	United States	Public Company	Medical Essentials (syringes, needles, catheters, sharps, specimen collection),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery, CSTD, hazardous drug detection),
BAXTER	United States	Public Company	Medical Products & Therapies (IV solutions, infusion systems, parenteral nutrition, dialysis-related therapies),Healthcare Systems & Technologies (smart beds, OR integration, monitoring, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
FRESENIUS SE & CO. KGAA	Germany	Public Company	Fresenius Helios (hospitals and outpatient care),IV generics and IV fluids,Clinical nutrition (enteral and parenteral),
ICU MEDICAL, INC.	United States	Public Company	Infusion pumps and hardware,Infusion consumables and vascular access (Clave, Neutron, Tego, disinfection caps),IV solutions and diluents,
TERUMO CORPORATION	Japan	Public Company	Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
MOOG, INC.	United States	Public Company	Military Aircraft,Commercial Aircraft,Space and Defense,
TELEFLEX INCORPORATED	United States	Public Company	Vascular access & emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck clips, MiniLap, staplers, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	China	Public Company	Patient monitoring, anesthesia, ventilators, and life-support,Ultrasound and medical imaging (radiology, emergency, critical care),In-vitro diagnostics (CLIA, chemistry, hematology),
CARDINAL HEALTH	United States	Public Company	Pharmaceutical Distribution (Branded & Generic),Specialty Pharmaceutical & Manufacturer Services,Medical Products & Cardinal-Branded Devices,
AVANOS MEDICAL, INC.	United States	Public Company	Digestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
NIPRO	Japan	Public Company	Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
JMS CO., LTD.	United States	Public Company	U.S. Retail Coffee,U.S. Retail Pet Foods and Snacks,U.S. Retail Frozen Handheld and Spreads,

KINDRED HEALTHCARE INC.

Kindred Healthcare Inc. is a private United States-based healthcare company founded in 1985 with 64,200 employees. The company operates healthcare facilities and provides related medical services.

ATS AUTOMATION TOOLING SYSTEMS INC

ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

CONVATEC

ConvaTec is a United Kingdom-based public company founded in 1978. The company manufactures and distributes medical devices and healthcare products globally.

IRADIMED CORPORATION

IraMed Corporation is a United States-based public company founded in 1992 with 166 employees. The company specializes in medical imaging and monitoring equipment.

POLY MEDICURE LTD.

Poly Medicure Ltd. is an Indian public company founded in 1995 with 3,082 employees. The company manufactures medical devices and healthcare products.

CONMED CORPORATION

ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical and medical devices.

MALLINCKRODT PLC

Mallinckrodt PLC is an Ireland-based private company with a history dating to 1867 and 2,687 employees. The company operates in the pharmaceutical and medical device sectors.

BECTON, DICKINSON AND COMPANY

Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company is a global leader in medical technology, manufacturing diagnostic and healthcare devices.

BAXTER

Baxter is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures medical devices, pharmaceuticals, and healthcare solutions.

FRESENIUS SE & CO. KGAA

Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. The company is a global healthcare company providing dialysis, infusion therapy, and hospital products.

ICU MEDICAL, INC.

ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures critical care medical devices and infusion therapy products.

TERUMO CORPORATION

Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices and healthcare products globally.

MOOG, INC.

Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

TELEFLEX INCORPORATED

Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care and surgical applications.

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company manufactures medical devices and diagnostic equipment.

CARDINAL HEALTH

Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a global healthcare services and products company serving hospitals and healthcare providers.

AVANOS MEDICAL, INC.

Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company manufactures and distributes medical devices for healthcare applications.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures medical devices, pharmaceuticals, and healthcare products.

JMS CO., LTD.

JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company manufactures medical devices and healthcare products.

Reasons to Buy this Report

Precise Market Sizing : Access validated market data specific to Denmark with exact valuations (USD 54.8M in 2026, USD 73.73M in 2031) and 6.1% CAGR for accurate business planning and investment decisions.
Demographic Insights : Understand Denmark's aging population dynamics and their direct impact on IV equipment demand, enabling targeted product development and market entry strategies for healthcare providers.
Regulatory Landscape : Gain clarity on Danish and EU regulatory requirements for IV equipment, ensuring compliance and reducing time-to-market for new infusion technologies and delivery systems.
Competitive Positioning : Identify market opportunities within Denmark's mature healthcare sector, benchmark against local competitors, and develop differentiation strategies for premium IV equipment solutions.
Growth Forecasting : Leverage 5-year forecast data to plan capacity expansion, supply chain investments, and market penetration strategies aligned with Denmark's projected 6.1% annual growth trajectory.

Frequently asked questions

What is the current size of Denmark's IV Equipment Market?

Denmark's IV Equipment Market is estimated at USD 54.8 million in 2026.

What is the projected market size for Denmark's IV Equipment Market by 2031?

Denmark's IV Equipment Market is projected to reach USD 73.73 million by 2031.

What is the CAGR for Denmark's IV Equipment Market?

Denmark's IV Equipment Market is expected to grow at a CAGR of 6.1% from 2026 to 2031.

What factors are driving growth in Denmark's IV Equipment Market?

Key drivers include Denmark's aging population, rising chronic disease prevalence, healthcare modernization initiatives, and technological advancements in infusion systems.

How does Denmark's regulatory environment impact the IV Equipment Market?

Denmark's stringent regulatory standards and emphasis on patient safety drive manufacturers to develop high-quality, innovative IV equipment that meets strict compliance requirements.

RESEARCH METHODOLOGY

This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.

Breakdown of Primary Interviews:

A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:

Note 1: Others include sales, marketing, and product managers.

Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,

Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.

To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:

Generating a list of major global players operating in the IV equipment market
Mapping annual revenues generated by major global players from the IV equipment segment (or nearest reported business unit/service category)
Revenue mapping of key players to cover a major share of the global market as of 2024
Extrapolating the global value of the IV equipment industry

Global IV Equipment Market Size: Top-down & Bottom-up Approach

IV Equipment Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.

Market Definition

IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.

Key Stakeholders

Manufacturers of IV equipment
Distributors of IV equipment
Hospitals, clinics, and infusion centers
Ambulatory surgery centers
Non-government organizations
Government regulatory authorities
Contract manufacturers & third-party suppliers
Research laboratories & academic institutes
Clinical research organizations (CROs)
Government & non-governmental regulatory authorities
Market research & consulting firms

Report Objectives

To define, describe, and forecast the IV equipment market based on type, application, end user, and region
To provide detailed information regarding the major factors influencing the growth potential of the global IV equipment market (drivers, restraints, opportunities, challenges, and trends)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global IV equipment market
To analyze key growth opportunities in the global IV equipment market for key stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the global IV equipment market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the global IV equipment market and comprehensively analyze their market shares and core competencies
To track and analyze the competitive developments undertaken in the global IV equipment market, such as agreements, collaborations, partnerships, expansions, and acquisitions

Customization Options

Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies

Geographic Analysis

Further breakdown of the Rest of Europe IV equipment market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, and Belgium
Further breakdown of the Rest of Asia Pacific IV equipment market into Taiwan, New Zealand, and Sri Lanka
Further breakdown of the Rest of Latin America IV equipment market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay

Get the Full IV Equipment Market Report

Full forecast, segment splits, and company analysis for all IV Equipment Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)